Evidence map›Paper›PMID 35226120›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2022

Image-level trajectory inference of tau pathology using variational autoencoder for Flortaucipir PET.

Jimin Hong, Seung Kwan Kang, Ian Alberts, Jiaying Lu, Raphael Sznitman, Jae Sung Lee, Axel Rominger, Hongyoon Choi, Kuangyu Shi, Alzheimer’s Disease Neuroimaging Initiative

Abstract read
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Multi-modal Imaging-based Pseudotime Analysis of Alzheimer progression.Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing · 2025
    Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jimin HongDepartment of Nuclear Medicine, Inselspital, University of Bern, Freiburgstrasse 18, 3010, Bern, Switzerland.
Seung Kwan KangDepartment of Nuclear Medicine, Seoul National University Hospital, 28 Yeon Gun, Jong Ro, Seoul, Republic of Korea.
Ian AlbertsDepartment of Nuclear Medicine, Inselspital, University of Bern, Freiburgstrasse 18, 3010, Bern, Switzerland.
Jiaying LuDepartment of Nuclear Medicine, Inselspital, University of Bern, Freiburgstrasse 18, 3010, Bern, Switzerland.
Raphael SznitmanARTORG Center, University of Bern, Bern, Switzerland.
Jae Sung LeeDepartment of Nuclear Medicine, Seoul National University Hospital, 28 Yeon Gun, Jong Ro, Seoul, Republic of Korea.
Axel RomingerDepartment of Nuclear Medicine, Inselspital, University of Bern, Freiburgstrasse 18, 3010, Bern, Switzerland.
Hongyoon ChoiDepartment of Nuclear Medicine, Seoul National University Hospital, 28 Yeon Gun, Jong Ro, Seoul, Republic of Korea. chy1000@snu.ac.kr.
Kuangyu ShiDepartment of Nuclear Medicine, Inselspital, University of Bern, Freiburgstrasse 18, 3010, Bern, Switzerland. kuangyu.shi@dbmr.unibe.ch.ORCID 0000-0002-8714-3084
Alzheimer’s Disease Neuroimaging Initiative

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAlzheimer's disease (AD) studies revealed that abnormal deposition of tau spreads in a specific spatial pattern, namely Braak stage. However, Braak staging is based on post mortem brains, each of which represents the cross section of the tau trajectory in disease progression, and numerous studies were reported that do not conform to that model. This study thus aimed to identify the tau trajectory and quantify the tau progression in a data-driven approach with the continuous latent space learned by variational autoencoder (VAE).

methodsA total of 1080 [

resultsWe identified four clusters that plausibly capture certain stages of AD and organized the clusters in the latent space. The inferred tau trajectory agreed with the Braak staging. According to the derived pseudo-time, tau first deposits in the parahippocampal and amygdala, and then spreads to the fusiform, inferior temporal lobe, and posterior cingulate. Prior to the regional tau deposition, amyloid accumulates first.

conclusionThe spatiotemporal trajectory of tau progression inferred in this study was consistent with Braak staging. The profile of other biomarkers in disease progression agreed well with previous findings. We addressed that this approach additionally has the potential to quantify tau progression as a continuous variable by taking a whole-brain tau image into account.

Indexed as

Alzheimer DiseaseCognitive DysfunctionBrainCarbolinesDisease ProgressionHumansPositron-Emission Tomographytau Proteins7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indoleCarbolinestau Proteins[18F]FlortaucipirAlzheimer’s diseaseHierarchical agglomerative clusteringMinimum spanning tree (MST)Positron emission tomography (PET)Variational auto-encoder (VAE)

Identifiers

PMID35226120
PMCPMC9250490

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.